Hailin (Sheena) Wang, PhD FDA

Dr. Sheena Hailin Wang is currently a chemistry reviewer in the office of new drug products (ONDP) in the Center for Drug Evaluation and Research (CDER), and has been with the agency since 2013. She has reviewed many submissions for injectable drug products including complex drug substances and products containing nanomaterials. Sheena has been involved in the guidance development for Inspection of Injectable Products for Visible Particulates Prior to joining FDA, Sheena worked at Novartis vaccine and Diagnostics where she was a formulation development scientist and process/product development lead with expertise in protein formulation and nanoemlusion preparation.

Sheena trained in chemistry and received her Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill with focus on process engineering and particulate sciences.

In addition, Sheena is a member of the Visible and Subvisible Particulate Matter Expert Committee of the United States of Pharmacopeia.